DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. AZOR (amlodipine besylate; olmesartan medoxomil) Daiichi Sankyo Patent number: 5,616,599 Expiration Date: Oct 25, 2016 BENICAR HCT (hydrochlorothiazide; olmesartan medoxomil) Daiichi Sankyo Patent number: 5,616,599 Expiration […]
Click here for reuse options!
Copyright 2016 Biotechblog
Like this:
Like Loading...
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. AZOR (amlodipine besylate; olmesartan medoxomil) Daiichi Sankyo Patent number: 5,616,599 Expiration Date: Oct 25, 2016 BENICAR HCT (hydrochlorothiazide; olmesartan medoxomil) Daiichi Sankyo Patent number: 5,616,599 Expiration […]
Click here for reuse options!
Copyright 2016 Biotechblog
Like this:
Like Loading...
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. AZOR (amlodipine besylate; olmesartan medoxomil) Daiichi Sankyo Patent number: 5,616,599 Expiration Date: Oct 25, 2016 BENICAR HCT (hydrochlorothiazide; olmesartan medoxomil) Daiichi Sankyo Patent number: 5,616,599 Expiration […]
Click here for reuse options!
Copyright 2016 Biotechblog
Like this:
Like Loading...
Medical marijuana is about to become a whole lot more accessible in Israel with pharmacies across the country expected to soon start providing the substance. Israel’s largest pharmacy chain, Super-Pharm, which has 225 branches across the country, has been meeting with health ministry officials over recent weeks to allow prescription dispensation of cannabis, Israeli newspaper […]
Like this:
Like Loading...
Rise and shine, everyone, another busy day is on the way. And after the presidential debate last night, being busy may be a good thing. Another good thing, of course, is a delicious cup of stimulation, which we are quaffing as we compose our prose. Please feel free to join us. Remember, no prescription is […]
Like this:
Like Loading...
This is a guest post from DrugPatentWatch. Do you have a response to DrugPatentWatch’s post? Respond in the comments section below. Pharmaceutical distributors face significant supply chain challenges Designing, implementing, and managing efficient product distribution can present pharmaceutical distributors and wholesalers with opportunities to create a long term strategic advantage. Distribution of pharmaceuticals has always been […]
Click here for reuse options!
Copyright 2016 Biotechblog
Like this:
Like Loading...
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. BELBUCA (buprenorphine hydrochloride) Endo Pharms Inc Patent number: 6,159,498 Expiration Date: Oct 18, 2016 BUNAVAIL (buprenorphine hydrochloride; naloxone hydrochloride) Biodelivery Sci Intl Patent number: 6,159,498 Expiration […]
Click here for reuse options!
Copyright 2016 Biotechblog
Like this:
Like Loading...
A novel home appliance designed by Finland Ltd’s VTT Technical Research Centre promises to grow plant cells into a healthy meal in one week – all on your kitchen table. Called the CellPod, the device’s first prototype is already hard at work producing food. The CellPod and seed cultures. Image credits VTT. In a world […]
Like this:
Like Loading...
As prescription drug costs continue to squeeze state budgets, a group of state health policy makers is offering some novel – and also some familiar – suggestions for coping. These include regulating the pharmaceutical industry as a utility, allowing states to operate as pharmacy benefit managers and waiving some provisions of the Medicaid program. In […]
Like this:
Like Loading...
A United Nations panel recently released a series of disastrous policy recommendations designed to increase access to medicines in developing countries. The panel ignored obvious solutions to help the one in three people in developing nations who lack regular access to medicines. Secretary General Ban Ki-Moon originally tasked the UN High-Level Panel on Access to […]
Like this:
Like Loading...